Enovis Corporation/$ENOV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Ticker
$ENOV
Sector
Primary listing
NYSE
Employees
7,367
Headquarters
Website
ENOV Metrics
BasicAdvanced
$1.7B
-
-$24.09
1.65
-
Price and volume
Market cap
$1.7B
Beta
1.65
52-week high
$49.38
52-week low
$25.47
Average daily volume
813K
Financial strength
Current ratio
2.225
Quick ratio
0.809
Long term debt to equity
69.044
Total debt to equity
71.22
Interest coverage (TTM)
0.90%
Profitability
EBITDA (TTM)
369.047
Gross margin (TTM)
60.57%
Net profit margin (TTM)
-61.22%
Operating margin (TTM)
3.46%
Effective tax rate (TTM)
-3.24%
Revenue per employee (TTM)
$300,000
Management effectiveness
Return on assets (TTM)
0.97%
Return on equity (TTM)
-51.02%
Valuation
Price to revenue (TTM)
0.77
Price to book
0.86
Price to tangible book (TTM)
-3.62
Price to free cash flow (TTM)
75.556
Free cash flow yield (TTM)
1.32%
Free cash flow per share (TTM)
0.401
Growth
Revenue change (TTM)
11.57%
Earnings per share change (TTM)
1,007.17%
3-year revenue growth (CAGR)
12.86%
10-year revenue growth (CAGR)
-5.92%
3-year earnings per share growth (CAGR)
281.55%
10-year earnings per share growth (CAGR)
17.26%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Enovis Corporation stock?
Enovis Corporation (ENOV) has a market cap of $1.7B as of November 28, 2025.
What is the P/E ratio for Enovis Corporation stock?
The price to earnings (P/E) ratio for Enovis Corporation (ENOV) stock is 0 as of November 28, 2025.
Does Enovis Corporation stock pay dividends?
No, Enovis Corporation (ENOV) stock does not pay dividends to its shareholders as of November 28, 2025.
When is the next Enovis Corporation dividend payment date?
Enovis Corporation (ENOV) stock does not pay dividends to its shareholders.
What is the beta indicator for Enovis Corporation?
Enovis Corporation (ENOV) has a beta rating of 1.65. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.